Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Lannett Company, Inc.

LCINYSE
Healthcare
Drug Manufacturers - Specialty & Generic
$0.69
$0.03(3.86%)
U.S. Market is Open • 12:50

Lannett Company, Inc. (LCI) Stock Overview

Explore Lannett Company, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap7.4M
P/E Ratio-0.03
EPS (TTM)$-19.14
ROE1.66%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

LCI Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Lannett Company, Inc. (LCI) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.03 and a market capitalization of 7.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
-72.36%
6-Month Change
-71.20%
Year-to-Date (YTD) Change
-67.79%
1-Year Change
-67.48%
3-Year Change
-97.62%
5-Year Change
-98.99%
All-Time (Max) Change
-93.57%

Contact Information

215 333 9000
1150 Northbrook Drive, Trevose, PA, 19053

Company Facts

5,640 Employees
IPO DateDec 13, 2013
CountryUS

Frequently Asked Questions